The global bronchiectasis drugs market is expected to post a CAGR close to 5% during the period 2019-2023, according to the latest market research report by ... Read more
Market Overview:
Bronchiectasis is a chronic respiratory condition characterized by the permanent dilation of the bronchi and bronchioles. The market for bronchiectasis drugs is driven by the increasing prevalence of the disease, especially in aging populations. The advantages of bronchiectasis drugs include alleviation of symptoms such as chronic cough, production of excess mucus, and difficulty breathing. These drugs also help in preventing and managing exacerbations ... Read more
The global bronchiectasis drugs market is estimated to be valued at US$ 303.8 million in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Bronchiectasis is a chronic respiratory disease characterized by the widening and inflammation of the bronchial tubes. This condition results in the build-up of mucus ... Read more
Market Overview:
Bronchiectasis is a chronic lung disease characterized by damage to the airways of the lungs which results in a build-up of excess mucus within the lungs. Some of the major symptoms of bronchiectasis include chronic cough, excessive phlegm production, weight loss, fatigue and recurring respiratory infections. Drugs to treat bronchiectasis aim to control or prevent exacerbations, loosen and thin out mucus, treat infections and improve symptoms and lung function. The ... Read more
The bronchiectasis drugs market consists of drugs used for the treatment of bronchiectasis. Bronchiectasis is a respiratory disorder characterized by abnormal, irreversible dilation of part or all of the bronchi in the lungs causing chronic cough with mucus. The increasing prevalence of respiratory diseases such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and asthma leading to bronchiectasis is a major factor driving the growth of the bronchiectasis drugs market. Drugs ... Read more
